...
neo-img

NeoGenomics Inc, Common Stock

NEO

NAQ

$17.97

+$0.24

(1.35%)

1D
Industry: Life Sciences Tools & Services Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.31B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
416.34K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$12.77 L
$21.22 H
$17.97

About NeoGenomics Inc, Common Stock

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. more

Industry: Life Sciences Tools & ServicesSector: Health Care

Returns

Time FrameNEOSectorS&P500
1-Week Return0.34%-3.72%-0.05%
1-Month Return19.72%-1.85%2.75%
3-Month Return10.04%-11.4%7.4%
6-Month Return37.18%-4.41%10.47%
1-Year Return-3.49%4.13%27.57%
3-Year Return-43.1%0.3%29.56%
5-Year Return-32.92%36.62%89.3%
10-Year Return335.11%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue408.83M444.45M484.33M509.73M591.64M[{"date":"2019-12-31","value":69.1,"profit":true},{"date":"2020-12-31","value":75.12,"profit":true},{"date":"2021-12-31","value":81.86,"profit":true},{"date":"2022-12-31","value":86.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue211.99M258.56M297.27M321.83M347.04M[{"date":"2019-12-31","value":61.09,"profit":true},{"date":"2020-12-31","value":74.5,"profit":true},{"date":"2021-12-31","value":85.66,"profit":true},{"date":"2022-12-31","value":92.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit196.84M185.89M187.06M187.90M244.60M[{"date":"2019-12-31","value":80.47,"profit":true},{"date":"2020-12-31","value":76,"profit":true},{"date":"2021-12-31","value":76.47,"profit":true},{"date":"2022-12-31","value":76.82,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin48.15%41.83%38.62%36.86%41.34%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":86.87,"profit":true},{"date":"2021-12-31","value":80.22,"profit":true},{"date":"2022-12-31","value":76.56,"profit":true},{"date":"2023-12-31","value":85.87,"profit":true}]
Operating Expenses183.83M199.88M305.81M341.00M341.25M[{"date":"2019-12-31","value":53.87,"profit":true},{"date":"2020-12-31","value":58.57,"profit":true},{"date":"2021-12-31","value":89.62,"profit":true},{"date":"2022-12-31","value":99.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income8.38M(2.13M)(9.99M)(153.11M)(107.74M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-25.44,"profit":false},{"date":"2021-12-31","value":-119.31,"profit":false},{"date":"2022-12-31","value":-1827.93,"profit":false},{"date":"2023-12-31","value":-1286.25,"profit":false}]
Total Non-Operating Income/Expense(8.44M)(7.08M)98.60M(3.23M)20.63M[{"date":"2019-12-31","value":-8.56,"profit":false},{"date":"2020-12-31","value":-7.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-3.27,"profit":false},{"date":"2023-12-31","value":20.93,"profit":true}]
Pre-Tax Income3.65M(14.06M)(15.07M)(159.34M)(97.10M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-385.62,"profit":false},{"date":"2021-12-31","value":-413.58,"profit":false},{"date":"2022-12-31","value":-4371.52,"profit":false},{"date":"2023-12-31","value":-2663.84,"profit":false}]
Income Taxes(4.36M)(18.23M)(6.73M)(15.09M)(9.13M)[{"date":"2019-12-31","value":-436100000,"profit":false},{"date":"2020-12-31","value":-1822800000,"profit":false},{"date":"2021-12-31","value":-672800000,"profit":false},{"date":"2022-12-31","value":-1509200000,"profit":false},{"date":"2023-12-31","value":-912900000,"profit":false}]
Income After Taxes8.01M4.17M(8.35M)(144.25M)(87.97M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":52.11,"profit":true},{"date":"2021-12-31","value":-104.26,"profit":false},{"date":"2022-12-31","value":-1801.77,"profit":false},{"date":"2023-12-31","value":-1098.78,"profit":false}]
Income From Continuous Operations8.01M4.17M(8.35M)(144.25M)(87.97M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":52.11,"profit":true},{"date":"2021-12-31","value":-104.26,"profit":false},{"date":"2022-12-31","value":-1801.77,"profit":false},{"date":"2023-12-31","value":-1098.78,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income8.01M4.17M(8.35M)(144.25M)(87.97M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":52.11,"profit":true},{"date":"2021-12-31","value":-104.26,"profit":false},{"date":"2022-12-31","value":-1801.77,"profit":false},{"date":"2023-12-31","value":-1098.78,"profit":false}]
EPS (Diluted)0.310.14(0.27)(0.56)(0.26)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":45.16,"profit":true},{"date":"2021-12-31","value":-87.1,"profit":false},{"date":"2022-12-31","value":-180.65,"profit":false},{"date":"2023-12-31","value":-83,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NEO
Cash Ratio 1.31
Current Ratio 1.99
Quick Ratio 1.91

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NEO
ROA (LTM) -2.76%
ROE (LTM) -8.38%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NEO
Debt Ratio Lower is generally better. Negative is bad. 0.45
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.55

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NEO
Trailing PE NM
Forward PE 222.22
P/S (TTM) 3.58
P/B 2.51
Price/FCF NM
EV/R 3.87
EV/Ebitda NM
PEG 3.02

FAQs

What is NeoGenomics Inc share price today?

NeoGenomics Inc (NEO) share price today is $17.97

Can Indians buy NeoGenomics Inc shares?

Yes, Indians can buy shares of NeoGenomics Inc (NEO) on Vested. To buy NeoGenomics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NEO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of NeoGenomics Inc be purchased?

Yes, you can purchase fractional shares of NeoGenomics Inc (NEO) via the Vested app. You can start investing in NeoGenomics Inc (NEO) with a minimum investment of $1.

How to invest in NeoGenomics Inc shares from India?

You can invest in shares of NeoGenomics Inc (NEO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NEO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in NeoGenomics Inc shares
What is NeoGenomics Inc 52-week high and low stock price?

The 52-week high price of NeoGenomics Inc (NEO) is $21.22. The 52-week low price of NeoGenomics Inc (NEO) is $12.77.

What is NeoGenomics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of NeoGenomics Inc (NEO) is

What is NeoGenomics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of NeoGenomics Inc (NEO) is 2.51

What is NeoGenomics Inc dividend yield?

The dividend yield of NeoGenomics Inc (NEO) is 0.00%

What is the Market Cap of NeoGenomics Inc?

The market capitalization of NeoGenomics Inc (NEO) is $2.31B

What is NeoGenomics Inc’s stock symbol?

The stock symbol (or ticker) of NeoGenomics Inc is NEO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top